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Abstract: Nanomedicine is on the cutting edge of technology applied to medical and biological 
sciences. Nanodevices, nanomaterials, nanoinstruments, nanotechnologies, and nanotechniques 
(laboratory methods and procedures) are important for the modern practice of medicine and 
essential for research that could stimulate the discovery of new medical advances. Accordingly, 
there is an eminent need for implementing an academic program in universities to teach this 
indispensable and pragmatic discipline, especially in the departments of graduate studies and 
research in the areas of pharmacology, genetic engineering, proteomics, and molecular and 
cellular biology.
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Introduction
To be in step with the future, it is necessary today for academic programs to exist that 
teach topics related to nanomedicine, an important and relatively recent technological 
advance in medicine. Such programs should be included in university departments 
for graduate studies and research, especially in the areas of pharmacology, genetic 
engineering, proteomics, and molecular and cellular biology. Later, as nanotechnology 
continues to develop, other areas will certainly be affected.
Research in nanomedicine began with discoveries of the novel physical and 
  chemical properties of various carbon-based materials that can only be detected 
in nanometer-sized structures. Nanomedicine is defined as the monitoring, repair, 
construction, and control of human biological systems at the cellular, molecular, and 
atomic levels using engineered nanodevices and nanostructures. Another definition is 
that provided by the National Institute of Health in its roadmap for medical research 
in nanomedicine, which states that nanomedicine is “an offshoot of nanotechnology, 
[which] refers to highly specific medical interventions at the molecular scale for curing 
disease or repairing damaged tissues, such as bone, muscle, or nerve”.1 Nanomedicine 
contains five main disciplines: analytical tools, nanoimaging, nanomaterials (medica-
tions, raw materials, and devices), novel therapeutic and drug delivery systems, as well 
as regulatory and toxicological issues related to clinical practice.1
Basic nanostructured materials, engineered enzymes, and the many products of 
biotechnology will most probably become essential elements in some areas of   medical, 
chemical, and biological applications. However, the full promise of nanomedicine 
is yet to be defined, as this will to a large extent depend on the development of new 
technology, such as precisely controlled or programmable medical nanomachines International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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and nanorobots to address medical problems. Moreover, the 
application of nanotechniques at the cellular, molecular, and 
atomic levels should certainly help in the understanding of the 
function of organisms, as well as in the development of better 
techniques for imaging, diagnosing, and treating disorders 
at the level of molecular and cellular biology.
Microscopic machines were first hypothesized by the 
Nobel Prize winning physicist Richard P Feynman, now con-
sidered the father of nanoscience, in 1959. His article “There 
is Plenty of Room at the Bottom” is considered a   classic in 
the establishment of the important possibilities for this field.2 
The main idea of this article was the ability to reduce the 
size of various apparatuses and at the same time increase 
their effectiveness, based on the manufacture of products by 
reordering atoms and molecules. Of particular   importance 
in his proposal was the reference to nanorobots, to be used 
in the manufacture of nanodevices, nanomaterials, and 
  nanomachines. He also mentioned the possibility of   creating 
a 100-fold improvement in the electron microscope.
Eric Drexler, considered the father of nanotechnology, 
wrote the popular books, Engines of Creation (1986) and 
Unbounding the future (1991), in which he announced 
the promise and warned of the dangers of molecular and 
atomic manipulation. In his more recent work, Nanosystems: 
  molecular machinery, manufacturing and, computation 
(1992), he predicted that nanotechnology will make the 
conventional means of manufacture obsolete.3 He proposed 
the concept of machines with the capability of ordering and 
reordering atoms in order to create precise molecular struc-
tures, thus resulting in the desired product. Such machines 
could even have the ability of self-reproduction.
Once nanomachines are available, programmable and 
controllable microscale robots comprised of nanoscale parts 
manufactured to nanometer precision will open new possi-
bilities related to curative and reconstructive procedures in 
the human body at the cellular, molecular, and atomic levels 
(perhaps at less than 100 nm). In keeping with the adage that 
“the best treatments are those that intervene the least”, the 
possibility of nanotechnology to greatly increase   knowledge 
of cellular and atomic events could lead to improved 
  treatments. Additionally, nanomedicine is on the cutting 
edge of medical practice and research, and for this reason it 
is an important focus of capital investment. Consequently, it 
is urgent that academic programs be implemented in order to 
teach this discipline in universities that have a medical and 
biological focus of study and research.
An academic discipline of nanomedicine at the uni-
versity level would allow students, teachers, technicians, 
and   researchers to become familiar with: (1) nanodevices, 
nanostructures, nanomaterials, nanostuffs, and precise and 
sophisticated nanoinstruments, such as those that could be 
used for molecular imaging and bedside biomarker testing and 
monitoring (Appendix 1); (2) the main categories of precise 
  nanotechnologies in real time (Appendix 2); and (3) techniques 
(laboratory methods and procedures) needed for furthering 
research (Appendix 3), including detailed procedures of nano-
biosensors for medical uses (Appendix 4). All of these elements 
of nanomedicine could be applied to cancer, cardiovascular 
diseases, inflammation, degenerative neurological diseases, 
toxicity, ethics, and societal and environmental impact.4
Perhaps one of the most important potentials for nano-
medical research is the gathering of extensive information 
about the chemical and physical properties of nanoscale bio-
logical structures. As the catalog of the interactions between 
individual molecules, cells, tissues, and organs develops, 
researchers will gain a greater understanding of the intricate 
operations of molecular structures, processes, and networks 
inside living cells based on the use of new probing tools. 
Consequently, scientists will be able to build new devices for 
a wide range of biomedical applications, such as detecting 
infectious agents or metabolic imbalances with tiny sensors, 
generating miniature devices that search for and destroy 
infectious agents, and replacing “broken” machinery inside 
cells with new nanoscale structures.4
Current applications
The following medical advances are among the existing uses 
of nanomedicine.
•	 Nanomaterials: nanotechnology used for subcutaneous 
treatments.5
•	 Nanoprobes in vivo: targeted nanoprobes reveal early 
time point kinetics in vivo by time-resolved magnetic 
resonance imaging (MRI).6
•	 Methods for the preparation of small interfering 
ribonucleic acids (siRNAs): a direct, efficient method 
for the preparation of siRNAs containing ribo-like 
north pseudo-sugars,7 and drug delivery of siRNA 
therapeutics.8
•	 Physical assessment of toxicology at nanoscale: 
nanodose-metrics and toxicity factor.9
•	 Nanomaterials for regenerative medicine: use of nano-
materials with applications for regenerative medicine.10
•	 Vascular toxicity: studies of vascular endothelial 
toxicity.11
•	 Nanocatalizers: molecular-level biological transporters 
capable of converting biomass into biofuel.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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•	 Nanoparticle devices: molecular-level biological trans-
porters that release medication in a precise and controlled 
manner throughout the organism, such as in target cells, 
for crossing biological barriers and for providing greater 
stability in the face of pathogenic deterioration, as well 
as use of nanoparticles for the treatment of cancer.12
Future directions and challenges
New opportunities will most certainly appear in relation to 
fighting disease as nanotechnology develops. Doctors may be 
able to search out and destroy the very first cancer cells before 
they lead to a destructive tumor in the body. Perhaps a broken 
part of a cell could be removed and replaced with a miniature 
biological machine. Pumps the size of molecules could pos-
sibly be implanted to deliver life-saving medicines precisely 
when and where they are needed. These scenarios are the 
long-term goals of the “nanomedicine roadmap”.4 With the 
inclusion of the academic discipline of nanomedicine in their 
programs, universities will be able to provide the personnel 
capable of accelerating the development of this field. Future 
possibilities include the following opportunities:
•	 Nanoneedles: the nucleus of live cells could be penetrated 
by nanoneedles used in conjunction with microscopy with 
the aim of introducing nucleic acids, proteins or other com-
pounds inside human cells, or even doing surgery; model-
ing the structure-property relationships of nanoneedles.13
•	 Environmental nanocatalizers: biological transporters 
capable of greatly improving catalytic converters cur-
rently used in automobiles, thus drastically reducing the 
pollution emitted.
•	 Nanobiosensors: sensors capable of detecting the pres-
ence of anthrax and other biological weapons; nanosen-
sors for probing live cells.14
•	 Dendrimers: artificial molecules designed to replace 
defective endogenous elements in the organism, induce 
the production or secretion of various molecules related 
to the immune response in case of being genetically 
deficient, or act as biological markers (for cancer therapy, 
for the detection of adherence to medication regimens, 
or for the evaluation of experimental results).15
•	 Nanodepots of insulin: microscopic deposits injected into 
the bloodstream that could act as an artificial pancreas, 
releasing insulin to counteract the effects of diabetes; 
similar technologies could also be employed to release 
dopamine into neurons as therapies for   Parkinson’s or 
Alzheimer’s disease.
•	 Titanium dioxide nanotubes: microscopic tubes that 
could clean polluted water.
•	 Carbon nanotubes: microscopic tubes aimed at replacing 
defective or absent genes; use of carbon nanotubes in vivo 
to characterize action mechanisms at the cellular level;16 
carbon nanotubes could reactivate synaptic connections 
and regenerate neurons damaged by an accident.
•	 Biological nanosensors: a set of ultramicroscopic and 
fine silicon threads.
•	 Molecular nanopyramids: these probes could possibly 
be released into the human body, with the capability of 
detecting and destroying the first cancer cells in the brain, 
heart, kidney, or lungs, without damaging neighboring 
tissue; they might also be able to detect viral or bacterial 
infections in an early stage before the immune system 
has begun to respond.
•	 Assembler nanomachines: machines based on the 
rearrangement of atoms and molecules to manufacture 
molecular components.
•	 Smart materials: these probe-like materials could poten-
tially detect subtle changes in body chemistry.
•	 Nanoparticles: microscopic tumor-destroying genes 
may possibly be transported to certain sites, directed 
with great precision to destroy the genetic information 
of tumors, with the aim of inactivating the target cells 
and impeding their reproduction; other genes may be 
transported to detect tiny alterations in proteins, as well 
as to scan tissue to ensure that the nanodevices are neatly 
congregated around the target.
•	 Nanorobots: these devices could be introduced into the 
human body to repair damage and combat infection and 
disease by acting on DNA without being detected and 
destroyed by the host immune system.17–22
•	 Nanobiochips: this advanced technology could work 
with MRI to supply an abundant amount of information 
about the human body.23
•	 Nanocomputers: computers could be developed made 
of material stronger than steel but with only 10% of its 
weight. These could possibly guide nanomachines for the 
purpose of examining, taking apart, and rebuilding dam-
aged cells, tissues, and organs through the reconstruction 
of their molecular structures; nanoinformatics could be 
applied to nanomedicine;24 new computers could search for 
a methodology that reproduces human organs in vitro.
Conclusion
The academic discipline of nanomedicine could be included in 
university curriculums for graduate students and researchers 
today in the fields of pharmacology, genetic   engineering, pro-
teomics, and molecular and cellular biology. Such   programs International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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would train personnel in order to accelerate advances of 
techniques, technology, and applications of nanomedicine. As 
such uses increase and broaden, other new programs will also 
become important elements of university curriculums.
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Appendix 1 Nanomaterials, nanodevices, nanoinstruments, and nanostuffs useful in nanomedicine
Nanostructures Nanoparticles Nanofibers Nanoplatforms
Nanodisks Nanoscaffolds Nanolabels Nanodiamonds
Nanoarrays Nanocomposites Nanopackages Nanobubbles
Nanobeads Nanofluidics Nanobiosensors Nanogadgets
Nanofilaments (silicone) Nanotargets Nanofilms Nanoscale
Nanotubes (carbon) Nanorods Nanoshapes Nanocoatings
Nanosuspensions Nanoemulsions Nanocarriers Nanospheres
Nanosystems Nanogels Nanocontainers Nanoproducts
Nanodrugs Nanovectors Nanohybrids Nanoreactives
Nanoscopic Nanoclusters Nanobullets Nanoknittings
Nanoswitches Nanoblobs Nanohazards Nanobodies
Nanosurfaces Nanopores Nanocatalysts Nanotools
Nanochips Nanorobots Nanocrystals Nanoneedles
Nanowires (silicone) Nanoshells Nanoencapsulation Nanoprobes
Nanolayers Nanomotors Nanomachines Nanocages
Nanoimpellers Nanomatrix Pharmacytes Dendrimers
Nanoscopic weapons Qubit sPION Quantum dots
Abbreviation: sPION, superparamagnetic iron oxide nanoparticles.
Appendix 2 Technologies
MIDD: molecular imaging drug delivery Artificial engineering
Nanoparticle drug delivery systems Nanoscopic medicine
Tissue engineering regenerative medicine Nanodimensional three
cell therapy regenerative medicine cell surface engineering
UMI: ultrasound molecular imaging Nanodiagnostics
Wireless endoscopy and biotelemetry regenerative medicine
AFM: atomic force microscopy Nanofluidic technology
Nanoparticles for molecular diagnostics stem cell tissue engineering
stem cell repair and therapy Nanocybernetics
stem cell therapy for cancer Laser nanoscissor
Nanoparticles for tracking stem cells sPr: surface plasmon 
resonance
Nanoscale single-cell or molecule 
identification
Molecular diagnostics
Nanotechnology-based cytogenetics endothelial cell repair
cancer molecular imaging Nanoscale probes
Nanotechnology-based biochips and 
microarrays
rAMiTs technology
Virtual reality stimulation Nanoproteomics
Phototermical therapy Organic electronic
Biodegradable polymeric nanoparticles as drug delivery devices
Modular robotics, multi-agent or swarm robotics, and utility fog
Appendix 3 (Continued)
Tissue specimen preparation Pcr-based detection
QD fluorescent nanoprobes QD-antibody conjugation
Image guided drug delivery Lasser nanoscissor
Fluorescence resonance energy transfer cryopreservation
cryogenic transmission electron  
microscopy
electrontomography
sLN: solid lipid nanoparticles Fluorescence nanoscopy
Magnetic resonance propulsion colorimetric method
electrostatic droplet generation Nanoencapsulation
Molecular imprinted polymer particles radioimmunotherapy
Affinity nanoliquid chromatography UV-bioimprint technique
Transmission electron microscopy Magneto electroporation
Contrast imaging technique BioMeMs
Nanomechanical holography Nanophotothermolisis
Plasmonics and sers nanoprobes Biomarker quantification
Isolation and analysis of individual 
biomolecules
MrI scanner
Nanolaser scanning confocal  
spectroscopy
Biobarcode assays
Gold nanoparticles for diagnostics Mass spectrometry
A spectroscopic assay based on sers standard 
photolithographic
Bioconjugated nanoparticle based bioassay
Multicolor oligonucleotide-functionalized QDs
sPION: super paramagnetic iron oxide nanoparticles
Nano dissection and nanoextraction of chromosomal DNA
Narrow emission spectra of nonorganic QD fluorophores
Application of nanoparticles for discovery of biomarkers
QDs for molecular diagnostics for cancer diagnosis and for viral diagnosis
Abbreviations:  eLIsA,  enzyme-linked  immunosorbent  assay;  MrI,  magnetic 
resonance  imaging;  PCR,  polymerase  chain  reaction;  QD,  quantum  dot;  SERS, 
surface-enhanced raman scattering.
Appendix 3 Techniques and methods
QDs broad absorption spectra Miniaturization top-down
FISH: florescent in situ hybridization Etching technique
Atomic force microscopy and  
quantum dot
The photostability
Scanning near-field optical microscopy Fluorescence microscopy
Functional polymer-coated nanoparticles MrI scanner
Lumininescent fluorescence microscopy confocal microscopy
Immunicon’s cell tracks technology eLIsA-based method
(Continued)
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Appendix 4 Nanobiosensors
Nanowire biosensors Ion channel switch biosensor  
technology
cantilevers as biosensors electrochemical nanobiosensors
carbon nanotube biosensors FreT-based DNA nanosensor
electronic nanobiosensors Quartz nanobalance DNA sensor
Viral nanosensor Nanosensors based on surface  
plasmon resonance
Optical biosensors using laser,  
nanoshell, sPr, sers, mrNA
PeBBLe
Abbreviations: FRET, fluorescence resonance energy transfer; PEBBLE, probes 
encapsulated by biologically localized embedding; sers, surface enhanced raman 
scattering; sPr, surface plasmon resonance.